Top

Pathology & Oncology Research

Published in:

01-03-1998 | Article

Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma

Authors: Gábor RÉPÁssy, Csaba Forster-HorvÁth, Attila JuhÁsz, Róza ÁDÁny, Anna TamÁssy, József TÍmÁr

Published in: Pathology & Oncology Research | Issue 1/1998

Title: Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma
Authors: Gábor RÉPÁssy
Csaba Forster-HorvÁth
Attila JuhÁsz
Róza ÁDÁny
Anna TamÁssy
József TÍmÁr
Publication date: 01-03-1998
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 1/1998
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/BF02904689

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/1998

Studies on the antibodies to human herpesvirus type 6 among Hungarian patients with asymptomatic HIV infection

P53 Expression in stage I squamous cell lung cancer

Coronary vasculopathy in polycythemia vera

Cellular alterations upon IR-Laser (890 nm) exposures,In Vivo

The complexity of the Epstein-Barr virus infection in humans

Embryotoxicity and teratogenicity of some derivatives of chloroethylaminophenylacetic acid

Keynote webinar | Spotlight on antibody–drug conjugates in cancer